“For me, meeting my peers, women who were living with HIV and who also had children – that was a turning point for me,” Angelina says. “I needed that kind of support. It really helped me to cope back then.”

Illumina, Inc. today announced that it has invested in six genomics startups for the fifth global funding cycle of Illumina Accelerator in the San Francisco Bay Area and Cambridge, UK.

Anyone can develop AUD, however, certain factors like biology and environment may contribute to a person's predisposition.

One in 3 people living with a disability in Europe suffer from gum disease due to struggles with their oral care routine. That’s why our Oral-B Europe team is leading an effort to make oral care more accessible and positive for all.

The idea of using one drug to treat many diseases is not entirely new. Historically, therapeutics like immunosuppressants or steroids have been used broadly across many immune-mediated diseases.

Ahead of the Global Fund Seventh Replenishment for 2024-2026, the innovative biopharmaceutical industry reaffirms its longstanding commitment to support the Global Fund mission to defeat HIV, TB, and malaria.

It's inevitable: Thanks to technology, we are going to see true breakthroughs in finding powerful medicines, and in treating, diagnosing and, hopefully, curing diseases.

All of our mental health stories, whether they play out on the big screen courtesy of a Hollywood film or are discussed within a small circle of our loved ones, are equally important and deserve to be told.

The Christian Community Health Center (CCHC) recently hosted a Health and Fun Fair in Chicago.

Illumina, a global leader in DNA sequencing and array-based technologies, announced the release of the full agenda for its inaugural Illumina Genomics Forum.

Jay and Sandra Aldrich experienced chronic pain for different reasons, but found relief in the same Medtronic therapy.

The Quest Diagnostics Quest for Health Equity team sponsored a summer intern program to help Scholars from the AMA’s HBCU, HSI, and the Bluford Healthcare Leadership Institute programs gain real-world experience in health equity.

At the 34th European Congress of Pathology (ECP) in Basel, Switzerland, September 3 to 7, 2022, pathologists from more than 100 countries will convene to share and gain insights on advancements in their field.

Predominantly Black and Hispanic lower-income communities are experiencing some of the most devastating impacts of the pandemic. Upon the launch of Q4HE, these vulnerable communities were the first priority.

Illumina a global leader in DNA sequencing and array-based technologies, announced the upcoming presentation of multiple oncology research abstracts at this year’s European Society of Medical Oncology (ESMO) annual meeting, September 9–13 in Paris.

As the internet of medical things (IoMT) evolves, the healthcare sector is experiencing a digital renaissance that is improving the experience of both patients and practitioners.

In February 2019, Eleonora was preparing to go out with a friend when she suddenly fainted. She woke up in the hospital near her home in Italy and didn’t remember a thing. But she will never forget the news the doctors delivered to her.

Illumina, a global leader in DNA sequencing and array-based technologies, today announced that it will feature International Tennis Hall of Fame member Chris Evert as a special guest at its inaugural Illumina Genomics Forum (IGF) on October 1.

During the Martha’s Vineyard African-American Film Festival August 5 to 13, Quest Diagnostics offered participants COVID-19 testing on the popular Massachusetts island off the coast of Cape Cod.

A snacking way of life is all about expanding that space between traditional meals and redefining what we eat and when we choose to do it.

Sanjiv Arora, VP of business development, and Leo Rapallini, VP of research & development, explain how trail-blazing technologies like the LINQ family of ICMs are a great tool in measuring infrequent – but important – cardiac events.

We connected with Jared Baeten, Gilead’s Vice President of HIV Clinical Development to discuss the top highlights from AIDS 2022, and ways the company is looking to help transform care and improve outcomes for people affected by HIV.

As the world’s leading provider of diagnostic information services, Quest stepped up and answered the call to play a central role in the national response to COVID-19.

Aflac, a leading provider of supplemental health insurance in the U.S.1, is kicking off its marketing campaign for the 2022-2023 college football season to shine a light on the gap between health insurance and medical bills.

Q4HE provided Cedarbrook with COVID-19 PCR testing for 600 staff members and 500 residents at their facility, with twice-weekly collections over a 12-week period—offering much-needed support to some of the most vulnerable members of the population.